figur8, Inc.


STEX25
Active dates:

December 1, 2017 - December 1, 2017
STEX25 Participation:
December 1, 2017 - November 30, 2018
Company information

2 Park Plaza, Suite 605
Boston, MA 02116
United States

Elevator Pitch

Elevator Pitch

FIGUR8 is the innovation leader in musculoskeletal biometrics, redefining the way MSK health is measured to deliver improved clinical and financial outcomes.Our bioMotion Assessment Platform (bMAP) is the first practical solution for measuring musculoskeletal function precisely and objectively, at any point of care.
Description

Description

FIGUR8 has developed the first musculoskeletal diagnostics decision support system of its kind that can accurately pinpoint the source and severity of an injury while showing real-time recovery visibility. FIGUR8 began as a collaboration between MIT Media Lab researchers, Massachusetts General Hospital Orthopaedics and the Boston Red Sox, in search of a better way to diagnose and treat injuries.
Technology Description

Technology Description

FIGUR8’s technology platform is a solution that takes data available in state-of-the-art sports labs adapted for use at any point of care and provides objective, actionable data around MSK function. This enables users to have a full picture view regarding joint motion and muscle function during dynamic activities, using movement as a biomarker to improve MSK health. Its powerful, lightweight system combines clinically smart biosensors, intuitive software and AI to improve musculoskeletal health at every point of care -- from injury through full recovery.